Madrigal Pharmaceuticals, Inc. MDGL Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s investing cash flow?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported investing cash flow of $192.19M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s investing cash flow increased by 17.3% year-over-year, from $163.88M to $192.19M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s investing cash flow?
- Over 2 years (2022 to 2024), Madrigal Pharmaceuticals, Inc.'s investing cash flow has grown at a 15.2% compound annual growth rate (CAGR), from $206.69M to -$274.39M.
- What does investing cash flow mean?
- The net cash result of buying and selling investments and physical assets.
- How do you interpret investing cash flow?
- Negative values often indicate heavy investment in securities or assets, while positive values may indicate the liquidation of investments to fund operations.
- How does investing cash flow compare across companies?
- Varies widely based on the company's stage of growth and treasury management strategy.